The DOI matches its Crossref record.
Epidemiological Analysis of Alcohol and Drug Use as Risk Factors for Psychotic Experiences
Abstract
Clinical and laboratory studies link alcohol and other drug use to the occurrence of psychotic experiences, but epidemiologic evidence has been lacking. In this study, the quantitative relationships between alcohol or other drug use and psychotic experiences were examined by analysis of prospective data from 4994 adult household residents sampled in a multisite survey of mental disorders in the population, the NIMH Epidemiologic Catchment Area Program. After control for sociodemographic factors and preexisting psychiatric conditions, the risk for onset of self-reported delusions or hallucinations was observed to be greater for daily users of marijuana or cocaine and for users of anxiolytics or sympathomimetics compared with nonusers. After control for daily cocaine use and alcohol disorder, the risk of onset of psychotic experiences for daily users of marijuana was double that for nonusers. Alcohol disorder in men was associated with eightfold risk and in women with threefold risk. Baseline depressive episodes, manic episodes, agoraphobia, and obsessive-compulsive disorder also were associated with increased risk of onset of psychotic experiences. — J Nerv Ment Dis 178:473-480, 1990
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the ECA study (20) daily cannabis use was associated with increased risk of psychotic experiences, although there was little evidence that ever use of cannabis was associated with these experiences.”
From Association Between Cannabis and Psychosis: Epidemiologic Evidence (2016) · cites this paper as [20]
In the citing paper
“In the ECA study (20) daily cannabis use was associated with increased risk of psychotic experiences, although there was little evidence that ever use of cannabis was associated with these experiences.”
From Association Between Cannabis and Psychosis: Epidemiologic Evidence (2016) · cites this paper as [20]
In the citing paper
“| ECA (20) | 2295 | Daily use of | Psychotic | 2.0 | Large sample | No |”
From Association Between Cannabis and Psychosis: Epidemiologic Evidence (2016) · cites this paper as [20]
Citations
Cited by
Sorted by citations
van Os, J., Linscott, R. J., Myin-Germeys, I., Delespaul, P., & Krabbendam, L. (2009) · Psychological Medicine · doi:10.1017/s0033291708003814 · Cited by 2,343
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.
Moore, T. H., Zammit, S., Lingford-Hughes, A., Barnes, T. R., Jones, P. B., Burke, M., & Lewis, G. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61162-3 · Cited by 2,224
Linscott, R. J., & van Os, J. (2013) · Psychological Medicine · doi:10.1017/s0033291712001626 · Cited by 1,181
Causal association between cannabis and psychosis: examination of the evidence
Arseneault, L., Cannon, M. D., Witton, J., & Murray, R. M. (2004) · The British Journal of Psychiatry · doi:10.1192/bjp.184.2.110 · Cited by 924
Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis
Marconi, A., Di Forti, M., Lewis, C. M., Murray, R. M., & Vassos, E. (2016) · Schizophrenia Bulletin · doi:10.1093/schbul/sbw003 · Cited by 899
Suspicious minds: The psychology of persecutory delusions
Freeman, D. (2007) · Clinical Psychology Review · doi:10.1016/j.cpr.2006.10.004 · Cited by 814
Hall, W., & Solowij, N. (1998) · The Lancet · doi:10.1016/s0140-6736(98)05021-1 · Cited by 778
Comorbidity between substance use disorders and psychiatric conditions.
Schuckit, M. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01592.x · Cited by 434
Cannabis as a risk factor for psychosis: Systematic review
Semple, D. M., McIntosh, A. M., & Lawrie, S. M. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105049040 · Cited by 420
Cannabis dependence and psychotic symptoms in young people
FERGUSSON, D. M., HORWOOD, L. J., & SWAIN-CAMPBELL, N. R. (2003) · Psychological Medicine · doi:10.1017/s0033291702006402 · Cited by 415
Association Between Cannabis and Psychosis: Epidemiologic Evidence
Gage, S. H., Hickman, M., & Zammit, S. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.08.001 · Cited by 379
Cannabis, the mind and society: the hash realities
Murray, R. M., Morrison, P. D., Henquet, C., & Forti, M. D. (2007) · Nature reviews. Neuroscience · doi:10.1038/nrn2253 · Cited by 329
Murray, R. M., Quigley, H., Quattrone, D., Englund, A., & Forti, M. D. (2016) · World Psychiatry · doi:10.1002/wps.20341 · Cited by 332
An epidemiologic investigation of potential risk factors for suicide attempts
Petronis, K. R., SAMUELS, J. F., Mościcki, E. K., & Anthony, J. C. (1990) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/bf00782961 · Cited by 290
Self-citationTesting hypotheses about the relationship between cannabis use and psychosis
Degenhardt, L. J., Hall, W., & Lynskey, M. T. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(03)00064-4 · Cited by 270
Cannabis use and risk of schizophrenia: a Mendelian randomization study
Vaucher, J., Keating, B. J., Lasserre, A. M., Gan, W., Lyall, D. M., Ward, J., Smıth, D. J., Pell, J. P., Sattar, N. A., Paré, G., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.252 · Cited by 280
Reasons for increased substance use in psychosis
Gregg, L., Barrowclough, C., & Haddock, G. (2007) · Clinical Psychology Review · doi:10.1016/j.cpr.2006.09.004 · Cited by 249
Substance use disorders in schizophrenia: review, integration, and a proposed model
Blanchard, J. (2000) · Clinical Psychology Review · doi:10.1016/s0272-7358(99)00033-1 · Cited by 240
Mueser, K. T., Yarnold, P. R., & Bellack, A. S. (1992) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1992.tb01441.x · Cited by 229
Cannabis use in young people: The risk for schizophrenia
Casadio, P., Fernandes, C., Murray, R. M., & Forti, M. D. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.04.007 · Cited by 220
Cannabis-associated psychosis: Neural substrate and clinical impact
Murray, R. M., Englund, A., Abi‐Dargham, A., Lewis, D. A., Forti, M. D., Davies, C., Sherif, M. A., McGuire, P. K., & D’Souza, D. C. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.06.018 · Cited by 210
Hall, W. (2009) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2009.02.013 · Cited by 206
Genetic predisposition to schizophrenia associated with increased use of cannabis
Power, R. A., Verweij, K. J. H., Zuhair, M., Montgomery, G. W., Henders, A. K., Heath, A. C., Madden, P. A. F., Medland, S. E., Wray, N. R., & Martin, N. G. (2014) · Molecular Psychiatry · doi:10.1038/mp.2014.51 · Cited by 196
Prevalence of alcohol and drug abuse in schizophrenic inpatients
Soyka, M., Albus, M., Kathmann, N., Finelli, A., Hofstetter, S., Holzbach, R., Immler, B., & Sand, P. (2005) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02190250 · Cited by 137
Cannabis use and psychosis: A review of clinical and epidemiological evidence
Hall, W., & Degenhardt, L. (2000) · Australian & New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.2000.00685.x · Cited by 183
Cannabis use and the risk of developing a psychotic disorder
Hall, W., & Degenhardt, L. J. (2008) · World Psychiatry · doi:10.1002/j.2051-5545.2008.tb00158.x · Cited by 187
Role of cannabis and endocannabinoids in the genesis of schizophrenia
Fernández‐Espejo, E., Viveros, M., Núñez, L., Ellenbroek, B. A., & de Fonseca, F. R. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1612-6 · Cited by 155
Delusions in the nonclinical population
Freeman, D. (2006) · Current Psychiatry Reports · doi:10.1007/s11920-006-0023-1 · Cited by 150
Prevalence of psychotic symptoms in substance users: a comparison across substances
Smith, M. J., Thirthalli, J., Abdallah, A. B., Murray, R. M., & Cottler, L. B. (2008) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2008.07.009 · Cited by 145
Psychosis and drug dependence: results from a national survey of prisoners
Farrell, M., Boys, A., Bebbington, P., Brugha, T. S., Coid, J. W., Jenkins, R., Lewis, G., Meltzer, H., Marsden, J., Singleton, N., et al. (2002) · The British Journal of Psychiatry · doi:10.1192/bjp.181.5.393 · Cited by 141
Is Cannabis Use a Contributory Cause of Psychosis?
Degenhardt, L. J., & Hall, W. (2006) · The Canadian Journal of Psychiatry · doi:10.1177/070674370605100903 · Cited by 134
Cannabis Use is Not Associated With the Development of Psychosis in an ‘Ultra’ High-Risk Group
Phillips, L., Curry, C., Yung, A. R., Yuen, H. P., Adlard, S., & McGorry, P. D. (2002) · Australian & New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.2002.01089.x · Cited by 124
Cannabis use and the Mental Health of Young People
Hall, W. (2006) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2006.01756.x · Cited by 126
Cannabis use and psychotic disorders: an update
Hall, W., Degenhardt, L. J., & Teesson, M. (2004) · Drug and Alcohol Review · doi:10.1080/09595230412331324554 · Cited by 107
Cannabis consumption and psychosis or schizophrenia development
Ortiz-Medina, M. B., Perea-Ortueta, M., Torales, J. C., Ventriglio, A., Vitrani, G., Aguilar, L., & Roncero, C. (2018) · International Journal of Social Psychiatry · doi:10.1177/0020764018801690 · Cited by 120
Hall, W. (1998) · Drug and Alcohol Review · doi:10.1080/09595239800187271 · Cited by 102
Davis, G. P., Compton, M. T., Wang, S., Levin, F. R., & Blanco, C. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.10.018 · Cited by 95
D’Souza, D. C. (2007) · International review of neurobiology · doi:10.1016/s0074-7742(06)78010-2 · Cited by 98
Hickman, M., Vickerman, P. T., Macleod, J., Kirkbride, J. B., & Jones, P. B. (2007) · Addiction · doi:10.1111/j.1360-0443.2006.01710.x · Cited by 101
Obstetric factors, urbanization and psychosis
Eaton, W. W., Mortensen, P. B., & Frydenberg, M. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00152-8 · Cited by 93
Effects of cannabis use on age at onset in schizophrenia and bipolar disorder
Binder, M. D., Wampers, M., Jendričko, T., Franić, T., Vidovic, D., Vriendt, N. D., Sweers, K., Peuskens, J., & van Winkel, R. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.07.003 · Cited by 95
WINSTOCK, A. R., & Barratt, M. J. (2013) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2292 · Cited by 83
Cannabis use and cognition in schizophrenia
Løberg, E. (2009) · Frontiers in Human Neuroscience · doi:10.3389/neuro.09.053.2009 · Cited by 85
Degenhardt, L. J., Saha, S., Lim, C. C. W., Aguilar‐Gaxiola, S., Al‐Hamzawi, A., Alonso, J., Andrade, L. H., Bromet, E. J., Bruffaerts, R., Caldas‐de‐Almeida, J. M., et al. (2017) · Addiction · doi:10.1111/add.14145 · Cited by 82
Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia
Fakhoury, M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9697-5 · Cited by 81
Minozzi, S., Davoli, M., Bargagli, A. M., Amato, L., Vecchi, S., & Perucci, C. A. (2010) · Drug and Alcohol Review · doi:10.1111/j.1465-3362.2009.00132.x · Cited by 80
Assessing evidence for a causal link between cannabis and psychosis: A review of cohort studies
McLaren, J., Silins, E., Hutchinson, D. M., Mattick, R. P., & Hall, W. (2009) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2009.09.001 · Cited by 75
Factors Moderating the Association between Cannabis Use and Psychosis Risk: A Systematic Review
van der Steur, S. J., Batalla, A., & Bossong, M. G. (2020) · Brain Sciences · doi:10.3390/brainsci10020097 · Cited by 78
Degenhardt, L. J., & Hall, W. (2002) · Current Psychiatry Reports · doi:10.1007/s11920-002-0026-5 · Cited by 68
Barriers to Optimal Care for Patients with Coexisting Substance Use and Mental Health Disorders
Todd, F. C., Sellman, J. D., & Robertson, P. (2002) · Australian & New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.2002.01049.x · Cited by 67
Why do patients with psychosis use cannabis and are they ready to change their use?
Kolliakou, A., Joseph, C., Ismail, K., Atakan, Z., & Murray, R. M. (2010) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2010.11.006 · Cited by 65
Cannabis Epidemiology: A Selective Review
Anthony, J. C., Lopez‐Quintero, C., & Alshaarawy, O. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160813214023 · Cited by 66
Self-citationRisk factors for the onset of depression in middle age and later life
Gallo, J. J., Royall, D. R., & Anthony, J. C. (1993) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/bf00801739 · Cited by 62
Self-citationLeweke, F. M., Gerth, C. W., & tter, J. K. (2004) · CNS Drugs · doi:10.2165/00023210-200418130-00005 · Cited by 60
Positive and negative symptoms in families with schizophrenia
Bassett, A. S., Collins, E. J., Nuttall, S., & Honer, W. G. (1993) · Schizophrenia Research · doi:10.1016/0920-9964(93)90033-f · Cited by 60
Comorbidity: Cannabis and Complexity
Raphael, B., Wooding, S., & Stevens, G. J. (2005) · Journal of Psychiatric Practice · doi:10.1097/00131746-200505000-00004 · Cited by 58
The Mental Health Risks of Adolescent Cannabis Use
Hall, W. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030039 · Cited by 54
Latent class analysis of substance use among adolescents presenting to urban primary care clinics
Bohnert, K. M., Walton, M. A., Resko, S. M., Barry, K., Chermack, S. T., Zucker, R. A., Zimmerman, M. A., Booth, B. M., & Blow, F. C. (2013) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2013.844821 · Cited by 53
Maremmani, I., Pani, P. P., Pacini, M., Bizzarri, J. V., Trogu, E., Maremmani, A. G. I., Gerra, G., Perugi, G., & Dell’Osso, L. (2010) · Annals of General Psychiatry · doi:10.1186/1744-859x-9-15 · Cited by 55
Schizophrenia and Substance Abuse: Prevalence Issues
el-Guebaly, N., & Hodgins, D. (1992) · Canadian journal of psychiatry. Revue canadienne de psychiatrie · doi:10.1177/070674379203701006 · Cited by 59
Colizzi, M., Ruggeri, M., & Bhattacharyya, S. (2020) · Frontiers in Psychology · doi:10.3389/fpsyg.2020.00833 · Cited by 51
Should Burden of Disease Estimates Include Cannabis Use as a Risk Factor for Psychosis?
Degenhardt, L. J., Hall, W., Lynskey, M. T., McGrath, J. J., McLaren, J., Calabria, B., Whiteford, H., & Vos, T. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000133 · Cited by 47
What every adolescent needs to know: Cannabis can cause psychosis
Shapiro, G. K., & Buckley-Hunter, L. (2010) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2010.04.002 · Cited by 48
Marijuana Use: Current Issues and New Research Directions
Sussman, S. Y., Stacy, A. W., Dent, C. W., Simon, T. R., & Johnson, C. A. (1996) · Journal of Drug Issues · doi:10.1177/002204269602600402 · Cited by 47
Auther, A. M., Cadenhead, K. S., Carrión, R. E., Addington, J., Bearden, C. E., Cannon, T. D., McGlashan, T. H., Perkins, D. O., Seidman, L. J., Tsuang, M. T., et al. (2015) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12382 · Cited by 46
Abnormalities in neuroendocrine stress response in psychosis: the role of endocannabinoids
Appiah‐Kusi, E., Leyden, E., Parmar, S. R., Mondelli, V., McGuire, P. K., & Bhattacharyya, S. (2015) · Psychological Medicine · doi:10.1017/s0033291715001786 · Cited by 46
Meta-analysis of neurocognition in young psychosis patients with current cannabis use
Bogaty, S. E. R., Lee, R. S. C., Hickie, I. B., & Hermens, D. F. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.01.010 · Cited by 44
State Cannabis Legalization and Psychosis-Related Health Care Utilization
Elser, H. C., Humphreys, K. N., Kiang, M. V., Mehta, S. S., Yoon, J. H., Faustman, W. O., & Matthay, E. C. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.52689 · Cited by 38
Cannabis and psychosis: Have we found the missing links?
Parakh, P., & Basu, D. (2013) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2013.03.012 · Cited by 41
The Cannabis Pathway to Non-Affective Psychosis may Reflect Less Neurobiological Vulnerability
Løberg, E., Helle, S., Nygård, M., Berle, J. Ø., Kroken, R. A., & Johnsen, E. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00159 · Cited by 40
Visual Acuity in Late Adolescence and Future Psychosis Risk in a Cohort of 1 Million Men
Hayes, J., Picot, S., Osborn, D., Lewis, G., Dalman, C., & Lundin, A. (2018) · Schizophrenia Bulletin · doi:10.1093/schbul/sby084 · Cited by 38
The link between cannabis use and psychosis: furthering the debate
Degenhardt, L. J. (2002) · Psychological Medicine · doi:10.1017/s0033291702007080 · Cited by 33
Use of Alternating Logistic Regression in Studies of Drug-Use Clustering
Bobashev, G., & Anthony, J. C. (2000) · Substance Use & Misuse · doi:10.3109/10826080009148432 · Cited by 30
Self-citationJacob, L., Smith, L., McDermott, D. T., Haro, J. M., Stickley, A., & Koyanagi, A. (2019) · Psychological Medicine · doi:10.1017/s003329171900309x · Cited by 32
The Development and Validation of the Beliefs about Paranoia Scale (Short Form)
Gumley, A. I., Gillan, K., Morrison, A. P., & Schwannauer, M. (2010) · Behavioural and Cognitive Psychotherapy · doi:10.1017/s135246581000055x · Cited by 30
Cannabis use and the mental health of young people
Hall, W. (2006) · Australian & New Zealand Journal of Psychiatry · doi:10.1111/j.1440-1614.2006.01756.x · Cited by 29
Is there a specific ‘cannabis psychosis’?
Hall, W., & Degenhardt, L. J. (2004) · Cambridge University Press eBooks · doi:10.1017/cbo9780511543630.008 · Cited by 27
Comorbid substance use disorders in schizophrenia: A latent class approach
Kerner, B. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.12.006 · Cited by 26
Kuzenko, N., Sareen, J., Beesdo‐Baum, K., Perkonigg, A., Höfler, M., Simm, J., Lieb, R., & Wïttchen, H. (2010) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2010.01633.x · Cited by 27
Rognli, E. B., Bramness, J. G., Skurtveit, S. O., & Bukten, A. (2016) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2016.12.007 · Cited by 27
Anhedonia and Social Adaptation Predict Substance Abuse Evolution in Dual Diagnosis Schizophrenia
Potvin, S., Stip, É., Lipp, O., Roy, M., Demers, M., Bouchard, R.-H., & Gendron, A. (2007) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990701764631 · Cited by 23
Anthony, J. C., Chen, C., & Storr, C. L. (2005) · Clinical Neuroscience Research · doi:10.1016/j.cnr.2005.08.002 · Cited by 23
Self-citationThe long-term treatment outcomes of depression and anxiety comorbid with substance abuse
BOVASSO, G. B. (2001) · The Journal of Behavioral Health Services & Research · doi:10.1007/bf02287233 · Cited by 21
Cannabis abuse and severity of psychotic and affective disorders in Israeli psychiatric inpatients
Katz, G., Durst, R., Shufman, E., Bar‐Hamburger, R., & Grunhaus, L. J. (2009) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2009.03.008 · Cited by 20
Cannabis as a potential causal factor in schizophrenia
Arseneault, L., Cannon, M. D., Witton, J., & Murray, R. M. (2004) · Cambridge University Press eBooks · doi:10.1017/cbo9780511543630.009 · Cited by 20
Exploring the relationship between cannabis use and psychosis
Zammit, S., & Lewis, G. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00843.x · Cited by 20
Relationship between Concurrent Substance Abuse in Psychiatric Patients and Neuroleptic Dosage
D’Mello, D. A., Boltz, M. K., & Msibi, B. (1995) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952999509002693 · Cited by 19
Is the grass greener? The link between cannabis and psychosis
McKay, D., & Tennant, C. C. (2000) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2000.tb123947.x · Cited by 20
Cannabis and psychopathology: The meandering journey of the last decade
Basu, D., & Ghosh, A. (2015) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.158134 · Cited by 18
Delta-8-THC association with psychosis: A case report with literature review
Miller, C. R., Burk, B. G., Fargason, R. E., & Birur, B. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1103123 · Cited by 16
Predicting changes in delusional ideation: The role of mindfulness and negative schemas
Oliver, J. E., McLachlan, K., Jose, P. E., & PETERS, E. R. (2011) · Psychology and Psychotherapy Theory Research and Practice · doi:10.1111/j.2044-8341.2011.02025.x · Cited by 19
Escamilla, M. A., Batki, S. L., Reus, V. I., Spesny, M., Molina, J., Service, S. K., Vinogradov, S., Neylan, T., Mathews, C. A., Meza, L., et al. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00373-1 · Cited by 15
The Use of the Case-Crossover Design in Studying Illicit Drug Use
Wu, L.-T. T., & Anthony, J. C. (2000) · Substance Use & Misuse · doi:10.3109/10826080009148431 · Cited by 16
Self-citationAnthony, J. C., & Etten, M. L. V. (1998) · Elsevier eBooks · doi:10.1016/b0080-4270(73)00180-2 · Cited by 15
Self-citationSubstance Abuse as a Risk Factor for Schizophrenia and Related Disorders
Bowers, M. B., Boutros, N. N., D’Souza, D. C., & Madonick, S. H. (2001) · International Journal of Mental Health · doi:10.1080/00207411.2001.11449509 · Cited by 14
Revisión sobre el consumo de cannabis como factor de riesgo de la esquizofrenia
Árias, F. (2007) · Adicciones · doi:10.20882/adicciones.316 · Cited by 12
Differential Diagnosis and Psychopharmacology of Dual Disorders
Decker, K. P., & Ries, R. K. (1993) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(18)30145-x · Cited by 13
Epidemiological Research on Cocaine Use in the USA
Anthony, J. C. (2007) · Novartis Foundation symposium · doi:10.1002/9780470514245.ch3 · Cited by 13
Self-citationThe X-box binding protein 1 (XBP1) gene is not associated with methamphetamine dependence
Morita, Y., Ujike, H., Tanaka, Y., Uchida, N., Nomura, A., Otani, K., Kishimoto, M., Morio, A., Inada, T., Harano, M., et al. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.04.014 · Cited by 12
Pignon, B., Sescousse, G., Amad, A., Benradia, I., Vaïva, G., Thomas, P., Geoffroy, P. A., Roelandt, J.-L., & Rolland, B. (2019) · Alcohol and Alcoholism · doi:10.1093/alcalc/agz077 · Cited by 16
Metadata
- Authors
- TIEN, A. Y., & ANTHONY, J. C.
- Affiliations
- Johns Hopkins University (US)
- Venue
- The Journal of Nervous and Mental Disease
- Published
- 1990-08
- Volume
- 178
- Issue
- 8
- Pages
- 473-480
- ISSN
- 0022-3018 (ISSN-L)
- OpenAlex
- W2019502220
- Cited by
- 175
- References
- 0
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2023: 3 · 2022: 3 · 2021: 2 · 2020: 9 · 2019: 3 · 2018: 5 · 2017: 7 · 2016: 8 · 2015: 6 · 2014: 7 · 2013: 6 · 2012: 5
- FWCI
- 4.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Nervous and Mental Disease (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01mh041908-04, 5r01da003992-04)
- National Institute of Mental Health (MH41908, MH-14592, T32MH014592)
- National Institute on Drug Abuse (DA03992)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Keywords
- alcohol consumption, drug use, psychotic experiences, delusions, hallucinations, cannabis, cocaine, anxiolytics, sympathomimetic drugs, alcohol-related disorders, substance use risk factors, depressive episodes, manic episodes, agoraphobia, obsessive-compulsive disorder
- MeSH terms
- Alcoholism, Mental Disorders, Marijuana Abuse, Cocaine, Delusions, Epidemiologic Methods, Hallucinations, Humans, Prospective Studies, Psychiatric Status Rating Scales, Psychotic Disorders, Risk Factors, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review